683 |
How to Practically Use FFR for Coronary Intervention? |
Chang-Wook Nam |
Apr. 21. 16 |
682 |
Vulnerability Assessment Using Physiologic Indices |
Bon-Kwon Koo |
Apr. 21. 16 |
681 |
Vulnerability Assessment Using OCT |
Evelyn Regar |
Apr. 21. 16 |
680 |
FFR and Clinical Outcomes: Evidence Has Never Been Stronger |
Seung-Jung Park |
Apr. 21. 16 |
679 |
FFR in the Bifurcation Treatment |
Farhat Fouladvand |
Apr. 21. 16 |
678 |
Hemodynamic Force and Coronary Plaque: Theoretical Evaluation of Mechanistic Effect |
Bon-Kwon Koo |
Apr. 21. 16 |
677 |
Coronary Blood Flow, Pressure and Resistance: How to Integrate, Interpret and Apply in Practice |
William F. Fearon |
Apr. 21. 16 |
676 |
Management of Stable Coronary Heart Disease with Objective Ischemia: COURAGE, FAME2 and Recent Meta-Analysis |
Gregg W. Stone |
Apr. 21. 16 |
675 |
SYNTAX-1, SYNTAX-II, SYNTAX-III: From Invasive to Non-Invasive Assessment of Coronary Stenosis |
Patrick W. Serruys |
Apr. 21. 16 |
674 |
New Findings from COLOR Registry |
Akiko Maehara |
Apr. 21. 16 |